Published in Hepatitis Weekly, February 15th, 1999
PEG-INTRON is a modified form of Schering-Plough's INTRON A (interferon alfa-2b, recombinant) which was developed using Enzon's PEG technology to have longer-acting properties and the potential to offer an improved side-effect profile.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.